Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.37) by 2.7 percent. This is a 24 percent increase over losses of $(0.50) per share from the same period last year. The company reported quarterly sales of $88.000 thousand which missed the analyst consensus estimate of $121.400 thousand by 27.51 percent. This is a 89.47 percent decrease over sales of $836.000 thousand the same period last year.